Victory Capital Management
CRBU icon

Victory Capital Management’s Caribou Biosciences CRBU Stock Holding History

Victory Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Buy
+10,309
New +$20.4K ﹤0.01% 2448
2024
Q4 		– Sell
-10,143
Closed -$19.9K – 2485
2024
Q3 		$19.9K Sell
10,143
-173
-2% -$354 ﹤0.01% 2444
2024
Q2 		$16.9K Buy
10,316
+85
+0.8% +$272 ﹤0.01% 2439
2024
Q1 		$52.6K Buy
+10,231
New +$63.1K ﹤0.01% 2373
2022
Q1 		– Sell
-81,160
Closed -$1.23M – 2740
2021
Q4 		$1.23M Sell
81,160
-3,770
-4% -$73.3K ﹤0.01% 1746
2021
Q3 		$2.03M Buy
+84,930
New +$2.08M ﹤0.01% 1599

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victory Capital Management's CRBU Position: Q2 2026 in Review

Victory Capital Management opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 10,309 shares worth $18.1K. The stake represents ﹤0.01% of the portfolio and ranks #2448 among its holdings. This is a return to the name: Victory Capital Management previously reported a position in CRBU as recently as Q3 2024.

Victory Capital Management first reported a position in CRBU in Q3 2021 and has held it in 6 quarters since. The position peaked at $2.03M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Victory Capital Management held 10,309 shares of Caribou Biosciences worth $18.1K as of Q2 2026.
  • Caribou Biosciences was a new Victory Capital Management position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2448 holding.
  • Victory Capital Management first reported a position in Caribou Biosciences in Q3 2021 and has held it in 6 quarters since.
  • Victory Capital Management's Caribou Biosciences position peaked at $2.03M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.